International Roadshow: New Advances in Endocrinology and Metabolic Diseases.
Charlotte SteenblockMaha Saber AyadStefan R BornsteinPublished in: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (2024)
Dear Readers,Currently, there is a myriad of new developments in the field of endocrinology. In particular, significant strides have been made in the development of poly-agonists for the treatment of type 2 diabetes and obesity 1 2. Poly-agonists represent a novel therapeutic approach by combining multiple actions within a single molecule, targeting multiple receptors simultaneously to achieve enhanced efficacy. These innovative compounds aim to address the complex interplay of hormonal pathways involved in glucose regulation and metabolism, offering potential breakthroughs in the management of diabetes and obesity.
Keyphrases
- single molecule
- type diabetes
- insulin resistance
- metabolic syndrome
- weight loss
- high fat diet induced
- weight gain
- atomic force microscopy
- cardiovascular disease
- living cells
- polycystic ovary syndrome
- glycemic control
- blood glucose
- adipose tissue
- cancer therapy
- body mass index
- physical activity
- combination therapy
- risk assessment